Alere Inc (ALR.N)

ALR.N on New York Stock Exchange

39.80USD
26 Nov 2014
Price Change (% chg)

$-0.07 (-0.18%)
Prev Close
$39.87
Open
$39.82
Day's High
$40.06
Day's Low
$39.78
Volume
107,477
Avg. Vol
158,272
52-wk High
$43.00
52-wk Low
$31.94

ALR.N

Chart for ALR.N

About

Alere Inc. is a provider of point-of-care diagnostics and services. The Company's products and services help healthcare practitioners make treatment decisions and improve outcomes for individuals living with chronic disease. The Company's portfolio also includes a range of health information solutions that access to critical... (more)

Overall

Beta: 1.92
Market Cap (Mil.): $3,331.39
Shares Outstanding (Mil.): 83.56
Dividend: --
Yield (%): --

Financials

  ALR.N Industry Sector
P/E (TTM): -- 31.67 39.03
EPS (TTM): -2.04 -- --
ROI: -2.64 8.44 17.31
ROE: -12.25 13.12 18.22
Search Stocks

Deals of the day- Mergers and acquisitions

(Adds SoftBank, JPMorgan Chase & Co, Zimmer Holdings, Vodafone Qatar, Volksbanken AG, Enel, UniCredit Bank Austria, Anadarko Petroleum and Alere)

02 Oct 2014

Alere in advanced talks to sell health management unit: sources

NEW YORK - Alere Inc is in talks to sell its health management business as the healthcare diagnostics and services company seeks to streamline operations after years of unprofitable acquisitions, according to people familiar with the matter.

02 Oct 2014

Alere in advanced talks to sell health management unit -sources

NEW YORK, Oct 2 - Alere Inc is in talks to sell its health management business as the healthcare diagnostics and services company seeks to streamline operations after years of unprofitable acquisitions, according to people familiar with the matter.

02 Oct 2014

Deals of the day- Mergers and acquisitions

(Adds SABMiller, Orange, BNP Paribas, AbbVie, America Movil, Microsoft, Club Mediterranee, JSW Steel, Alere, GFI Group, AngloGold Ashanti, Qatar National Bank and Telekom)

15 Sep 2014

Alere's former CEO offers to take company private

- Alere Inc's former Chief Executive Ron Zwanziger said he intends to take the diagnostic device and service provider private in a deal that values the company at $3.82 billion.

15 Sep 2014

UPDATE 1-Alere's former CEO offers to take company private

Sept 15 - Alere Inc's former Chief Executive Ron Zwanziger said he intends to take the diagnostic device and service provider private in a deal that values the company at $3.82 billion.

15 Sep 2014

Alere's former CEO offers to take company private

Sept 15 - Alere Inc's former Chief Executive Ron Zwanziger said he intends to take the diagnostic company private in a deal that values it at $3.82 billion.

15 Sep 2014

CORRECTED-U.S. CDC recommends combo HIV test for faster detection of virus

(Corrects in paragraph 3 to show company making recommended test is Bio-Rad Laboratories, not Alere Inc)

27 Jun 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks